Pramod Pujari

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Hitt Sharma, Sameer Parekh, Pramod Pujari et al. · The Lancet Oncology · 2023 · 41 citations

Veterinary Medicine, Immunology, Pediatrics +11

A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive bladder cancer

Rajeev Sood, Hitt Sharma, Bhuvaneshwari Sharma et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 15 citations

Medicine, Oncology, Urology +6

Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin

Vishal Rathod, Laxmikant Kadam, Manish Gautam et al. · Frontiers in Immunology · 2023 · 11 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17